FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223965021> ?p ?o ?g. }

• W4223965021 endingPage "2523" @default.
• W4223965021 startingPage "2511" @default.
• W4223965021 abstract "Diabetic nephropathy (DN) represents the most serious complication of diabetes. Previous studies have shown that the activation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) are linked to inflammation in the development of DN. Sclareol, a natural diterpene compound, has beneficial effects on inflammation. Thus, we hypothesized that sclareol might prevent DN via anti-inflammatory actions. This study aimed to investigate the actions of sclareol in the progression of DN, and explored the related molecular mechanism. Sclareol treatment significantly alleviated renal dysfunction, fibrosis, and inflammatory cytokine levels in a dose-dependent manner in diabetic mice. Moreover, sclareol inhibited the activations of MAPKs and NF-κB in diabetic kidney tissues. The therapeutic effects of sclareol were confirmed under high levels of glucose in SV40 cells, and sclareol prevented high glucose-induced fibrosis and inflammatory responses, which was largely driven by MAPKs and NF-κB inhibitions. In particular, MAPKs inhibitors mixture could suppress the NF-κB pathway and release of inflammatory cytokines that sclareol was involved in. In conclusion, sclareol has benefits for diabetes-induced renal dysfunction, which was partially associated with amelioration of fibrosis and inflammation via mediation of the MAPK/NF-κB signaling pathway. Sclareol may be a promising agent for preventing the progression of DN." @default.
• W4223965021 created "2022-04-19" @default.
• W4223965021 creator A5010526490 @default.
• W4223965021 creator A5029667848 @default.
• W4223965021 creator A5030475937 @default.
• W4223965021 creator A5034787812 @default.
• W4223965021 creator A5044544424 @default.
• W4223965021 creator A5062709913 @default.
• W4223965021 creator A5074286511 @default.
• W4223965021 creator A5074398142 @default.
• W4223965021 creator A5080712099 @default.
• W4223965021 creator A5085329434 @default.
• W4223965021 creator A5088971629 @default.
• W4223965021 date "2022-04-17" @default.
• W4223965021 modified "2023-10-16" @default.
• W4223965021 title "Sclareol ameliorates hyperglycemia‐induced renal injury through inhibiting the <scp>MAPK</scp>/<scp>NF‐κB</scp> signaling pathway" @default.
• W4223965021 cites W1858846386 @default.
• W4223965021 cites W2003376310 @default.
• W4223965021 cites W2005753081 @default.
• W4223965021 cites W2020133142 @default.
• W4223965021 cites W2026672268 @default.
• W4223965021 cites W2273144352 @default.
• W4223965021 cites W2500767839 @default.
• W4223965021 cites W2569047325 @default.
• W4223965021 cites W2606386867 @default.
• W4223965021 cites W2618746079 @default.
• W4223965021 cites W2620689414 @default.
• W4223965021 cites W2625727020 @default.
• W4223965021 cites W2737074341 @default.
• W4223965021 cites W2792548369 @default.
• W4223965021 cites W2800293042 @default.
• W4223965021 cites W2883321985 @default.
• W4223965021 cites W2907541540 @default.
• W4223965021 cites W2938991264 @default.
• W4223965021 cites W2974085358 @default.
• W4223965021 cites W3012694474 @default.
• W4223965021 cites W3021747439 @default.
• W4223965021 cites W3080224090 @default.
• W4223965021 cites W3091987428 @default.
• W4223965021 cites W3093832000 @default.
• W4223965021 cites W3094988574 @default.
• W4223965021 cites W3096852685 @default.
• W4223965021 cites W3126008093 @default.
• W4223965021 cites W3131856051 @default.
• W4223965021 cites W3192827506 @default.
• W4223965021 doi "https://doi.org/10.1002/ptr.7465" @default.
• W4223965021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35434887" @default.
• W4223965021 hasPublicationYear "2022" @default.
• W4223965021 type Work @default.
• W4223965021 citedByCount "9" @default.
• W4223965021 countsByYear W42239650212022 @default.
• W4223965021 countsByYear W42239650212023 @default.
• W4223965021 crossrefType "journal-article" @default.
• W4223965021 hasAuthorship W4223965021A5010526490 @default.
• W4223965021 hasAuthorship W4223965021A5029667848 @default.
• W4223965021 hasAuthorship W4223965021A5030475937 @default.
• W4223965021 hasAuthorship W4223965021A5034787812 @default.
• W4223965021 hasAuthorship W4223965021A5044544424 @default.
• W4223965021 hasAuthorship W4223965021A5062709913 @default.
• W4223965021 hasAuthorship W4223965021A5074286511 @default.
• W4223965021 hasAuthorship W4223965021A5074398142 @default.
• W4223965021 hasAuthorship W4223965021A5080712099 @default.
• W4223965021 hasAuthorship W4223965021A5085329434 @default.
• W4223965021 hasAuthorship W4223965021A5088971629 @default.
• W4223965021 hasConcept C126322002 @default.
• W4223965021 hasConcept C134018914 @default.
• W4223965021 hasConcept C164027704 @default.
• W4223965021 hasConcept C185592680 @default.
• W4223965021 hasConcept C2776914184 @default.
• W4223965021 hasConcept C2777730290 @default.
• W4223965021 hasConcept C51551487 @default.
• W4223965021 hasConcept C55493867 @default.
• W4223965021 hasConcept C555293320 @default.
• W4223965021 hasConcept C57074206 @default.
• W4223965021 hasConcept C62478195 @default.
• W4223965021 hasConcept C71924100 @default.
• W4223965021 hasConcept C98274493 @default.
• W4223965021 hasConceptScore W4223965021C126322002 @default.
• W4223965021 hasConceptScore W4223965021C134018914 @default.
• W4223965021 hasConceptScore W4223965021C164027704 @default.
• W4223965021 hasConceptScore W4223965021C185592680 @default.
• W4223965021 hasConceptScore W4223965021C2776914184 @default.
• W4223965021 hasConceptScore W4223965021C2777730290 @default.
• W4223965021 hasConceptScore W4223965021C51551487 @default.
• W4223965021 hasConceptScore W4223965021C55493867 @default.
• W4223965021 hasConceptScore W4223965021C555293320 @default.
• W4223965021 hasConceptScore W4223965021C57074206 @default.
• W4223965021 hasConceptScore W4223965021C62478195 @default.
• W4223965021 hasConceptScore W4223965021C71924100 @default.
• W4223965021 hasConceptScore W4223965021C98274493 @default.
• W4223965021 hasFunder F4320321001 @default.
• W4223965021 hasIssue "6" @default.
• W4223965021 hasLocation W42239650211 @default.
• W4223965021 hasLocation W42239650212 @default.
• W4223965021 hasOpenAccess W4223965021 @default.
• W4223965021 hasPrimaryLocation W42239650211 @default.
• W4223965021 hasRelatedWork W2028293395 @default.
• W4223965021 hasRelatedWork W2056415482 @default.

• next